Verano Holdings (VRNO) Capital Expenditures Growth (3y) (2024 - 2026)
Verano Holdings (VRNO) Capital Expenditures Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 28.56% |
| 10 | Verano Holdings | 1.98 Bn | 1.91 Bn | 98.98 Mn | 20.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.42% |
| Dec 31, 2025 | 27.87% |
| Sep 30, 2025 | -58.77% |
| Jun 30, 2025 | 30.70% |
| Mar 31, 2025 | -34.03% |
| Dec 31, 2024 | -33.90% |
| Sep 30, 2024 | 23.33% |